These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2719740)
1. Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types. Tiozzo R; Cingi MR; Pietrangelo A; Albertazzi L; Calandra S; Milani MR Arzneimittelforschung; 1989 Jan; 39(1):15-20. PubMed ID: 2719740 [TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane. Tiozzo R; Reggiani D; Croce MA; Calandra S; Osima B; Bianchini P Drugs Exp Clin Res; 1997; 23(3-4):103-9. PubMed ID: 9403270 [TBL] [Abstract][Full Text] [Related]
3. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment. Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988 [TBL] [Abstract][Full Text] [Related]
5. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization. Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. Majack RA; Clowes AW J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099 [TBL] [Abstract][Full Text] [Related]
8. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity. Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058 [TBL] [Abstract][Full Text] [Related]
9. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm. Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709 [TBL] [Abstract][Full Text] [Related]
10. Effects of heparinoids on the sclerotic reaction of rat thoracic aorta to injury: comparison between standard and low-molecular-weight heparins in vitro and in vivo. Chajara A; Heudes D; Peronneau I; Jarnet J; Basset A; Capron L J Cardiovasc Pharmacol; 1994 Jun; 23(6):995-1003. PubMed ID: 7523793 [TBL] [Abstract][Full Text] [Related]
11. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity. Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. Reilly CF; Fritze LM; Rosenberg RD J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540 [TBL] [Abstract][Full Text] [Related]
13. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. Caleb BL; Hardenbrook M; Cherington V; Castellot JJ J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458 [TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Orlandi A; Ropraz P; Gabbiani G Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646 [TBL] [Abstract][Full Text] [Related]
15. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation. Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Clowes AW; Clowes MM Lab Invest; 1985 Jun; 52(6):611-6. PubMed ID: 4040189 [TBL] [Abstract][Full Text] [Related]
18. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle. Newcomb PM; Herman IM J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730 [TBL] [Abstract][Full Text] [Related]
19. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures. Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843 [TBL] [Abstract][Full Text] [Related]
20. Unfractionated heparin and low molecular weight heparin do not inhibit the growth of proliferating human arterial smooth muscle cells in culture. Stavenow L; Lindblad B; Xu CB Eur J Vasc Endovasc Surg; 1995 Aug; 10(2):215-9. PubMed ID: 7655975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]